newsfilter
← Latest News
PR Newswire·

NewcelX CEO Issues Letter to Shareholders

NewcelX Ltd. (Nasdaq: NCEL), a Swiss clinical-stage biopharmaceutical company developing cell-based and small-molecule therapies for...